Efficacy and Safety of SPC1001 in Patients With Essential Hypertension

NCT06826872 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension, Essential
Cardiovascular Diseases
Cardiology

Interventions

DRUG: SPC 1001 Mid2
DRUG: SPC 2002
DRUG: SPC 2003
DRUG: SPC 2004

Sponsor

Shin Poong Pharmaceutical Co. Ltd.